33458-27-4

Basic information

• Product Name: 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester
• Synonyms: 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester;2-Oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester
• CAS NO: 33458-27-4
• Molecular Formula: C₇H₁₀N₂O₃
• Molecular Weight: 170.1659
• Mol File: 33458-27-4.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester(33458-27-4)
• EPA Substance Registry System: 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester(33458-27-4)

Safety Data

• Hazardous Substances Data: 33458-27-4(Hazardous Substances Data)

Usage

General Description

5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester, also known as ethyl 3,4-dihydro-2-oxopyrimidine-5-carboxylate, is a chemical compound with the molecular formula C8H10N2O3. 5-PyriMidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester is an ethyl ester derivative of 3,4-dihydro-2-oxopyrimidine-5-carboxylic acid and is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It is a white to off-white solid with a molecular weight of 182.17 g/mol and a melting point of 76-78°C. 5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-2-oxo-, ethyl ester is a versatile intermediate in organic synthesis and has applications in the production of various chemical compounds.

Upstream product

• 763-69-9 ethyl 3-ethoxypropionate 
• 1086272-71-0 Ethyl (2E)-2-(ethoxymethyl)-3-methoxyacrylate 
• 57-13-6 urea 
• 879008-23-8 (Z)-ethyl-2-(ethoxymethyl)-3-methoxyacrylate 
• 2974-30-3 (Z)-ethyl-2-(ethoxymethyl)-3-methoxyacrylate 

Downstream Products

• 110099-99-5 2-CHLOROPYRIMIDINE-5-CARBONYLCHLORIDE 
• 1753-50-0 2-chloropyrimidine-5-carbonitrile 
• 1213234-72-0 (5-{2-[1-(3,4,5-Trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidin-5-yl}-2H-tetrazol-2-yl)acetic acid 
• 856595-94-3 2-chloropyrimindine-5-carboxaminde 
• 1213234-95-7 2-[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidine-5-carbonitrile 
• 1213234-96-8 5-(2H-tetrazol-5-yl)-2-[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidine 
• 1213234-97-9 ethyl (5-{2-[1-(3,4,5-trichlorobenzyl)-1H-1,2,3-triazol-4-yl]pyrimidin-5-yl}-2H-tetrazol-2-yl)acetate 
• 603965-77-1 ethyl 2-(piperazin-1-yl) pyrimidine-5-carboxylate 
• 1235450-27-7 Ethyl 2-((2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methylamino)pyrimidine-5-carboxylate 
• 1235450-94-8 methyl 2-(((2-(4-(aminomethyl)phenyl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate 
• 1235450-97-1 methyl 2-(((2-(3-(aminomethyl)phenyl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate 
• 1235451-07-6 ethyl 2-(((2-(4-aminophenyl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate 
• 1235451-15-6 ethyl 2-(((2-chloro-4-(phenylamino)thieno[3,2-d]pyrimidine-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxylate 
• 1235450-95-9 ethyl 2-(((2-(4-(acetamidomethyl)phenyl)-4-morpholinothieno[3,2-d]pyrimidine-6-yl)Methyl)(methyl)amino)pyrimidine-5-carboxylate 

Relevant articles and documents

COMBINATION THERAPY WITH A PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY

The invention provides a method of treating cancer in a subject in need thereof, comprising administering to the subject: (a) a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein R is hydrogen or an acyl group; and (b) a PD-1 signaling inhibitor; wherein the compound of Formula I or pharmaceutically acceptable salt thereof and the PD-1 signaling inhibitor are administered in amounts which in combination are therapeutically effective. The invention further provides a pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, a PD-1 signaling inhibitor and a pharmaceutically acceptable carrier or excipient.

PURINYL-N-HYDROXYL PYRIMIDINE FORMAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF

The Invention relates to the field of chemical medicines, and particularly to a purinyl-N-hydroxyl pyrimidine formamide derivative, preparation methods and uses thereof. The Invention provides a purinyl-N-hydroxyl pyrimidine formamide derivative with a st

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

The invention provides a compound of Formula I, Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.